Progress in diagnosis and treatment of kaposiform hemangioendothelioma |
Click here to download the full text |
Citation of this paper:YANG Zhang-fu, HU Bo, FU Pei-yao, YU Min-cheng, XU Yang*.Progress in diagnosis and treatment of kaposiform hemangioendothelioma[J].Chinese Journal of Clinical Medicine,2019,26(2):286-291 |
Hits: 1694 |
Download times: 1374 |
|
Abstract:Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor with local invasiveness. It is found predominantly in infants and children, and often accompanied by the Kasabach-Merritt phenomenon (KMP). There is no evidence-based standard for KHE treatment yet. The sirolimus is expected to be the first-line drug due to its efficacy and safety. This article reviews the progress of the diagnosis and treatment of KHE. |
keywords:kaposiform hemangioendothelioma Kasabach-Merritt phenomenon sirolimus vascular tumor |
HTML View Full Text View/Add Comment Download reader |
|
|
|